Probiotics and the gastrointestinal tract:Where are we in 2005?

被引：5
|
作者：
IritChermesh [1 ]
RamiEliakim [1 ]
机构：
[1] Gastroenterology Department Rambam Medical Center.Haifa.Israel
来源：
World Journal of Gastroenterology | 2006年 / 06期
关键词：
Probiotics; Inflammatory bowel disease; Crohn’s disease; Lactose intolerance; Antibiotic associated diarrhea; Rotavirus; Pseudomembranous colitis; Clostridium dificile; Irritable bowel syndrome; Toll like receptor 9;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
1002 ; 100201 ;
摘要：
Probiotic agents are live microbes or components ofmicrobes that have a positive effect on the host.Theyexert their action through interplay with the immunesystem of the host.Some of this effect is local andsome is systemic.The full story is yet to be discovered.Probiotics have a definite positive effect on rotavirusdiarrhea,post antibiotic diarrhea and pouchitis.Theirexact role in inflammatory bowel disease,irritablebowel syndrome,other forms of infectious diarrhea,and prevention of cancer is yet to be determined.Thisreview summarizes the data about probiotics in theseconditions.
引用
收藏
页码：853 / 857
页数：5
相关论文
共 50 条
  • [31] EFFECTS OF PROBIOTICS IN THE ULTRASONOGRAPHIC FINDINGS OF THE GASTROINTESTINAL TRACT IN BEAGLE DOGS
    Feliciano, M. A. R.
    Leite, C. A. L.
    Silveira, T.
    Nepomuceno, A. C.
    Vicente, W. R. R.
    VETERINARY RADIOLOGY & ULTRASOUND, 2010, 51 (02) : 209 - 209
  • [32] Influence of Probiotics on Dietary Protein Digestion and Utilization in the Gastrointestinal Tract
    Wang, Jing
    Ji, Haifeng
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2019, 20 (02) : 125 - 131
  • [33] In vitro test to evaluate survival in the gastrointestinal tract of commercial probiotics
    da Silva, Maritiele Naissinger
    Tagliapietra, Bruna Lago
    Flores, Vinicius do Amaral
    Pereira dos Santos Richards, Neila Silvia
    CURRENT RESEARCH IN FOOD SCIENCE, 2021, 4 : 320 - 325
  • [34] Probiotics to enhance anti-infective defences in the gastrointestinal tract
    Gill, HS
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2003, 17 (05) : 755 - 773
  • [35] Probiotics for prevention of necrotizing enterocolitis: Where do we stand?
    Barbian, Maria Estefania
    Patel, Ravi Mangal
    SEMINARS IN PERINATOLOGY, 2023, 47 (01)
  • [36] Where are we with postmenopausal hormone therapy in 2005?
    Lam, PM
    Chung, TKH
    Haines, C
    GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (05) : 248 - 256
  • [37] Prebiotics and Probiotics in Ulcerative Colitis: Where Do We Stand?
    Rogler, Gerhard
    DIGESTION, 2011, 84 (02) : 126 - 127
  • [38] Atration of atrial fibrillation in 2005: where are we?
    Pratola, Claudio
    Baldo, Elisa
    Notarstefano, Pasquale
    Toselli, Tiziano
    Guardigli, Gabriele
    Ferrari, Roberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2005, 6 (11) : 720 - 723
  • [39] Sedation in gastrointestinal endoscopy: Where are we at in 2014?
    Ferreira, Alexandre Oliveira
    Cravo, Marilia
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2015, 7 (02): : 102 - 109
  • [40] Immunotherapy in Biliary Tract Cancers: Where Are We?
    Kalyan, Aparna
    Khosla, Harshit
    Kim, Richard D.
    CURRENT ONCOLOGY REPORTS, 2022, 24 (12) : 1821 - 1828
12345